Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Mankind Pharma Ltd. ( (IN:MANKIND) ) just unveiled an announcement.
Mankind Pharma Ltd. has announced a scheduled board meeting on July 31, 2025, to review and approve the unaudited financial results for the quarter ending June 30, 2025, and to consider declaring an interim dividend for the financial year 2025-26. In compliance with SEBI regulations, the company has closed its trading window until August 2, 2025, to prevent insider trading, reflecting its adherence to regulatory standards and commitment to transparency.
More about Mankind Pharma Ltd.
Mankind Pharma Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of a wide range of healthcare products. The company is known for its commitment to providing affordable and quality medicines, catering primarily to the Indian market.
Average Trading Volume: 18,587
Current Market Cap: 1064B INR
Learn more about MANKIND stock on TipRanks’ Stock Analysis page.